Abstract
Oral-intragastric inoculation of infant CFW mice with Candida albicans, leading either to lethality or to persistent infection of long duration, provides a useful model for study of the host-pathogen interrelationships in candidosis. Mice were most susceptible to the lethal effects of challenge when 4 to 6 days of age, increasingly resistant up to 10 to 11 days, and then resistant to doses of C. albicans lethal for the younger animals. Older mice harboring persistent infections of the gastrointestinal tract, originally initiated when the animals were 6 days old, were used to study the effects of agents which commonly are administered to cancer patients or which are known to predispose to candidosis. The broad-spectrum antibiotic chloramphenicol, cortisone acetate, X-irradiation, or single high doses of cyclophosphamide (Cytoxan) resulted in markedly enhanced levels of C. albicans in the gastrointestinal tract without systemic spread. Repeated smaller doses of Cytoxan, or treatment with methotrexate or a combination of cortisone acetate and Cytoxan, produced gastrointestinal candidosis associated with invasion and systemic spread. The data indicate that the persistently infected animals provide a realistic model for studying tre...Continue Reading
References
Aug 1, 1979·Infection and Immunity·L M PopeL J Berry
Feb 1, 1978·The Journal of Infectious Diseases·J Z Montgomerie, J E Edwards
Oct 1, 1979·American Journal of Clinical Pathology·S Y Cho, H Y Choi
Jul 1, 1978·American Journal of Clinical Pathology·J C ParkerR S Lee
Jul 1, 1977·American Journal of Clinical Pathology·R L MyerowitzC M Allen
Jan 11, 1976·International Journal of Radiation Oncology, Biology, Physics·J S Remington, S E Anderson
Mar 22, 1969·Lancet·W KrauseK Wulf
May 1, 1974·Annals of Surgery·H H StoneJ Z Cuzzell
Sep 1, 1972·Medicine·P ErasP Sherlock
Jul 1, 1974·Infection and Immunity·M N Guentzel, L J Berry
Jan 1, 1968·Digestion·G VolkheimerH Wendlandt
Aug 1, 1980·Infection and Immunity·J R WingardW H Burns
Feb 1, 1981·Infection and Immunity·L H FieldL J Berry
Jan 1, 1980·The Tohoku Journal of Experimental Medicine·T UmenaiH Fujimoto
Sep 1, 1980·The Medical Clinics of North America·T L Ray
Citations
Jan 1, 1992·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·H Sandovsky-LosicaE Segal
Jun 4, 1998·Mycoses·A Polak
Jul 1, 1997·Toxicologic Pathology·D J HerzykP J Bugelski
Sep 6, 2001·Microbiology·P K MukherjeeM A Ghannoum
Jan 1, 1989·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·G T ColeL M Pope
May 1, 1992·European Journal of Epidemiology·T J Walsh, P A Pizzo
May 19, 2000·Infection and Immunity·L de RepentignyP Belhumeur
Jul 2, 2005·Current Microbiology·Swarajit K Biswas, W LaJean Chaffin
Dec 17, 2008·Future Microbiology·Rosalía Diez-Orejas, Elena Fernández-Arenas
Apr 14, 2004·Mycoses·J BłaszkowskaP Kurnatowski
Apr 1, 1993·Mycopathologia·R A Greenfield, W A Joyce
Jan 1, 1990·Mycoses·G T ColeK R Seshan
Nov 1, 1990·Mycoses·J PospísilO Vejbora
May 29, 1999·International Journal of Immunopharmacology·A M BadgerP J Bugelski
Apr 1, 1984·Applied and Environmental Microbiology·E BalishK F Bartizal
Jun 2, 2000·Journal of Clinical Microbiology·K A AndrutisS Tzipori
Jun 1, 1990·Infection and Immunity·G SamonisG P Bodey
May 1, 1985·Infection and Immunity·S Walbaum, L Dujardin
Aug 1, 1990·Journal of Clinical Microbiology·G T ColeK R Seshan
Jan 1, 1982·Antimicrobial Agents and Chemotherapy·C Herrera, M N Guentzel
Feb 1, 1993·Infection and Immunity·S L VargasW T Hughes
Nov 1, 1992·Infection and Immunity·L de RepentignyL G Mathieu
Jul 1, 1987·Infection and Immunity·O Ekenna, R J Sherertz
Jul 1, 1996·Antimicrobial Agents and Chemotherapy·A M FlatteryK Bartizal
Aug 4, 2004·Current Opinion in Microbiology·Louis de Repentigny
May 1, 1990·Infection and Immunity·R F HectorM S Collins